Assessment of everolimus in addition to calcineurin inhibitors reduction in maintenance renal transplant recipients (ASCERTAIN)
- Registry ID
- EUCTR2004-002267-24
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Novartis Pharma Services AG
- Start date
- 2005-07-29
- Completion date
- 2009-08-18
- Last update
- 2026-08-16
Conditions
- Renal transplantation
- Chronic allograft nephropathy profilaxis in renal transplant patients in mainteinance
Summary
The primary objective is to investigate whether initiation of everolimus together with reduction or discontinuation of CNI in maintenance renal transplant patients with renal impairment will improve renal function. This will be assessed by comparing renal function evaluated by measured glomerular filtration rate among 3 groups of patients at month 24.
Locations
- , , Finland
- , , Czechia
- , , Spain
- , , Sweden
- , , Denmark
- , , Hungary
- , , Italy
View on source registry